PATRICK COONEY: Open Payments
NPI 1811527682 · NEW BALTIMORE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,011 in 468 payments from 25 companies in 2025. Trend: 2023 $15,158 · 2024 $35,216 · 2025 $35,011
Speaker / faculty: $16,026Honoraria: $9,250Food & beverage: $7,852Travel & lodging: $1,764Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $12,858 |
| Axsome Therapeutics, Inc. | 53 | $11,447 |
| Teva Pharmaceuticals USA, Inc. | 40 | $5,163 |
| Neurocrine BioSciences, Inc. | 46 | $964 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $555 |
| Otsuka America Pharmaceutical, Inc. | 19 | $449 |
| Vanda Pharmaceuticals Inc. | 21 | $401 |
| Corium, LLC | 20 | $398 |
| Collegium Pharmaceutical, Inc. | 26 | $348 |
| Janssen Pharmaceuticals, Inc | 20 | $309 |
Products named: VRAYLAR, Auvelity, UZEDY, INGREZZA, CAPLYTA, REXULTI, FANAPT, Azstarys.
Industry payments across MI — which companies pay providers there.
